U.S. botulinum toxin market held majority of the market share and valued at 3,349.7 million in the year 2018. Rising prevalence of medical conditions such as cervical dystonia, severe primary axillary hyperhidrosis and chronic migraine will foster market growth in the country. Moreover, presence of major industry player such as Allergan will significantly drive the U.S. market. —
Request a sample of this premium report at: https://www.marketstudyreport.com/request-a-sample/2100696/?utm_source=marketersmedia.com-SP
Botulinum Toxin Market will exceed USD 8.5 billion by 2025; as per a new research report. Increase in the prevalence of cervical dystonia and spasticity as well as number of cases of chronic migraine is expected to boost botulinum toxin market during the forecast period. Moreover, surge in adoption rate of non-surgical botulinum toxin procedures, due to their minimally invasive or non-invasive nature coupled with growing influence of aesthetics among the population is augmenting market growth over the forecast timeframe.
Botulinum toxin A held significant market share, accounting for a total value of USD 3,323.6 million in 2018 and is expected to grow at a robust rate during the projected timeframe. High growth is due to rise in demand for such products due to its wide range of applications in aesthetic procedures. Moreover, increasing number of FDA approvals for botulinum toxin A products will further augment segment growth.
However, side effects such as rash, allergic reactions, back and neck pain, nausea and shortness of breath are hindering the adoption rate of botulinum toxin in aesthetic as well as therapeutic application. Additionally, high cost associated with aesthetic procedures coupled with poor reimbursement coverage will further hamper market growth.
Spas & cosmetic centers is forecasted to expand at 9.5% CAGR during the projected timeframe. Growing trends of minimally invasive aesthetic surgeries coupled with increasing number of spas and cosmetic centers in developed and developing economies will render positive effect on segment growth. Moreover, availability of state-of-the-art facilities will further influence people to prefer spas and cosmetic centers over any other settings.
Male segment is forecasted to expand at 10.4% CAGR during the forecast timeframe. Botulinum toxin is known as a neuromodulator that reduces the speed of ageing. Male segment is expected to witness significant growth owing to increasing number of minimally invasive procedures coupled with growing trends in males to look young. Moreover, major influence of social media on frequently changing beauty trends will further drive the market.
Request a discount on standard prices of this premium report at: https://www.marketstudyreport.com/check-for-discount/2100696/?utm_source=marketersmedia.com-SP
Medical botulinum toxin segment accounted for market share of 57.3% in 2018. Growing prevalence of spasticity and cervical dystonia coupled with increasing incidence of migraine will propel medical botulinum toxin segment. Additionally, increasing awareness among the population about various medical applications of botulinum toxin A will further propel segmental growth.
Botulinum toxin procedures are growing at a robust rate among the middle-aged population. People between the age group of 40-54 generated maximum revenue of USD 2,649.6 million in 2018. Factors such as growing disposable income and increasing awareness about various aesthetic procedures are the major factors augmenting segmental growth.
Brazil botulinum toxin market is forecasted to expand at 10.7% CAGR during the analysis period. The region offers lucrative growth opportunity owing to increasing adoption rate of non-invasive procedures. Moreover, growing awareness among the population about various medical as well as aesthetic applications of botulinum toxin will further augment market growth.
Industry players having a strong foothold include Allergan, Eisai Co., Ltd., Galderma S.A., Hugel Inc., and Hugh Source International Ltd. Other notable participants include Ipsen, Medytox Inc., Merz Pharma and Revance Therapeutics, Inc. To expand their industry presence, many established firms are entering in sparsely addressed high potential regions. Additionally, novel product launch in developed as well as developing economies by these companies enable them to serve a broader customer base.
Table of Contents:
Chapter 1. Methodology
1.2. Market definition
1.3. Forecast parameters
1.4. Data sources
126.96.36.199. Paid sources
188.8.131.52. Unpaid sources
Chapter 2. Executive Summary
2.1. Botulinum toxin industry 360 degree synopsis, 2014 - 2025
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Gender trends
2.1.5. Age group trends
2.1.6. End-use trends
2.1.7. Regional trends
Chapter 3. Botulinum Toxin Industry Insights
3.1. Industry segmentation
3.2. Industry landscape, 2014 - 2025
3.3. Industry impact forces
3.3.1. Growth drivers
3.3.2. Industry pitfalls & challenges
3.4. Growth potential analysis
3.4.1. By product
3.4.2. By application
3.4.3. By gender
3.4.4. By age group
3.4.5. By end-use
3.5. Regulatory scenario
3.6. Porter's analysis
3.7. Competitive landscape, 2017
3.7.1. Strategy dashboard
3.8. PESTEL analysis
Chapter 4. Botulinum Toxin Market, By Product
Chapter 5. Botulinum Toxin Market, By Application
Chapter 6. Botulinum Toxin Market, By Gender
Chapter 7. Botulinum Toxin Market, By Age Group
Chapter 8. Botulinum Toxin Market, By End-use
Chapter 9. Botulinum toxin Market, By Region
Chapter 10 Botulinum toxin Market Company Profiles
For more information on this report at: https://www.marketstudyreport.com/reports/botulinum-toxin-market/?utm_source=marketersmedia.com-SP
Global Dermal Fillers Botulinum Toxin Market Report 2019 - Market Size, Share, Price, Trend and Forecast
Global Dermal Fillers Botulinum Toxin Market Report 2019 - Market Size, Share, Price, Trend and Forecast is a professional and in-depth study on the current state of the global Dermal Fillers Botulinum Toxin industry. The key insights of the report:
Marketstudyreport.com allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report LLC
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Release ID: 88934767